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Background: White spot lesions and gingivitis represent common, yet challenging, dilemmas for orthodontists.
Fluoride has shown some benefit as a protective measure against demineralization; however, this is usually
insufficient for orthodontic patients with less than ideal oral hygiene. Dentifrices containing calcium sodium
phosphosilicate bioactive glass (NovaMin) have been proposed to aid in prevention of white spot lesions and
gingival inflammation. Thus, the purpose of this study was to determine if the use of NovaMin reduces the
formation of white spot lesions and improves gingival health in orthodontic patients.
Methods: This was a prospective, double-blind, randomized controlled trial. Forty-eight patients undergoing
orthodontic treatment were randomly allocated to two groups. The control group consisted of 24 patients who
received over-the-counter fluoride toothpaste (Crest®), while the study group consisted of 24 patients who were
given the test dentifrice (ReNew™) containing 5 % NovaMin and fluoride. Patients were followed up for 6 months
on a monthly basis. Decalcification, gingival health, plaque, and bacteria levels were evaluated every 3 months.
Statistical analysis was performed using both parametric and non-parametric tests to identify differences between
groups at different time points.
Results: There were no significant differences between the groups in regard to changes in white spot lesions,
plaque, or gingival health (P > 0.05). There was a trend toward improvement in white spot lesions found in subjects
using Crest® at the 3-month time point; however, this was not sustained throughout the study.
Conclusions: Our results indicate that a toothpaste containing NovaMin does not differ significantly compared to
traditional fluoride toothpaste for improving white spot lesions and gingivitis in orthodontic patients.
Keywords: White spot lesion; NovaMin; Orthodontics; FluorideBackground
White spot lesions (WSL) are the earliest macroscopic
evidence of enamel caries [1] and represent a com-
mon, yet challenging, dilemma for orthodontists.
Increased plaque retention leads to an increased
microbial load which produces acid that lowers the
pH. Subsequently, there is an increase in the porosity* Correspondence: wrody@dental.ufl.edu
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remineralize. The majority of demineralization leading
to WSL occurs in the subsurface region of the enamel
[2]; thus, the outer 10 to 30 μm of enamel surface is
believed to stay intact due to the supersaturation of
fluorapatite [3]. In this scenario, calcium and phos-
phate ions have difficulty reaching the subsurface
enamel layer to help remineralize [4]. Furthermore,
salivary proteins known to inhibit demineralization,
such as proline-rich proteins and statherin, are not
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changes the refractive index of the enamel [5] and mani-
fests clinically as a milky white opacity [6] or WSL.
Development of WSL during fixed appliance therapy
can occur rapidly. Studies by both O’Reilly et al. [7] and
Ogaard et al. [8] both show development of clinically
visible WSL in orthodontic patients that occurred in
4 weeks or less. This approximates a minimal time inter-
val between consecutive orthodontic appointments. WSL
in orthodontic patients are typically found near the
bracket base and usually have a crescent shape. They can
also be detected under loose bands or as linear defects
near the margin of the band [6]. Gorelick et al. [9] studied
the incidence of WSL in orthodontic patients and found
that almost 50 % of orthodontic patients developed at
least one white spot lesion during the course of treatment.
Maxillary lateral incisors showed the highest incidence of
white spot lesions, followed by mandibular canines and
first premolars.
The presence of WSL upon completion of orthodon-
tic treatment is a major detractor from what would
otherwise be a great esthetic result [10]. Both early
detection and treatment can prove difficult at times,
making prevention a critical component of managing
this clinical problem. ReNew™ (Sultan Health Care,
Englewood, NJ), a prescription-strength dentifrice con-
taining 5 % calcium sodium phosphosilicate bioactive
glass (NovaMin) and 5000 ppm neutral sodium fluor-
ide, has been proposed to aid in prevention and reversal
of white spot lesions. When immersed in an aqueous
environment, sodium (Na) particles from the NovaMin
begin to exchange with H+ ions. This allows for the
release of calcium and phosphate from the calcium
sodium phosphosilicate particles. The reaction of so-
dium ions with the hydrogen cations causes transient
increase in pH that facilitates precipitation of calcium
and phosphate from both the NovaMin and saliva to
form a calcium phosphate layer on the tooth surface.
These reactions and depositions continue until the
depositions eventually crystallize into hydroxycarbonate
apatite, which is structurally and chemically similar to
biological hydroxyapatite [11]. It has also been pro-
posed that a combination of fluoride and NovaMin is
beneficial and synergistic in remineralization efforts.
This is due to the ability of NovaMin to provide cal-
cium and phosphorous ions in the production of fluora-
patite [4, 12]. The availability of these ions is normally
the limiting factor in fluoride treatment. Additionally,
the transient increase in pH created by NovaMin can
help resist demineralization.
NovaMin has also been shown to be beneficial in redu-
cing gingivitis. A study by Tai et al. [13] showed improve-
ment in gingival health over a 6-week period with the use
of a dentifrice containing NovaMin. The exact mechanismof NovaMin’s antibacterial property remains unclear; how-
ever, it is proposed that the sodium and calcium content of
the product affects bacterial liquid balance [14]. Therefore,
the aim of this study was to determine if the use of a denti-
frice containing calcium sodium phosphosilicate bioactive
glass (NovaMin) reduces formation of white spot lesions
and gingivitis in orthodontic patients.
Methods
The study protocol was reviewed and approved by the
Institutional Review Board at the University of Florida
(Study # 329-2011). Patients receiving orthodontic care
with full-fixed appliances in the graduate orthodontic
clinic were selected according to the following criteria: (1)
between the ages of 12 and 25, (2) moderate or poor oral
hygiene, (3) good general health, (4) at least 6 months of
orthodontic treatment remaining, (5) fixed orthodontic
appliances present on all maxillary and mandibular anter-
ior teeth, and (6) under the care of a general dentist at
time of recruitment. Informed consent was obtained from
the patient or the parent/legal guardian if under the age of
18. Patients with excellent oral hygiene, active dental
caries, positive pregnancy test, or active periodontal dis-
ease were excluded from the study.
The sample size for this study was based on compar-
ing the two groups for mean change in decalcification
index (baseline to 6 months), and standard deviation
estimates were from a previous study in a similar
group of subjects undergoing orthodontic treatment.
A two-sided two-sample t-test was used, with level of
significance set at 0.05. With a sample size of 20 to 25
per group, we have a greater than 0.85 power to detect
a difference of 1.0 unit change in the decalcification
index (assuming a s.d. of 1.0) and a greater than 0.80
power to detect a difference of 1.25 if the s.d. is larger
than anticipated (1.3).
This was a prospective, double-blind, randomized clinical
trial. Subjects were initially screened and assigned to the
control or experimental groups by means of block
randomization. A total of 48 patients were enrolled in
the study. Data was collected on 44 patients through-
out the 6-month study period. Lack of data on the four
subjects was due to possible allergic reaction in one
patient and missed appointments by the other three.
The control group encompassed 24 patients (15 males/
9 females) with a mean age of 15.3 years who received
commercial toothpaste containing 0.15 % fluoride
(Crest®, Procter and Gamble, Cincinnati, OH). The ex-
perimental group consisted of 24 patients (17 males/7
females) with a mean age of 15.6 years who were given
a toothpaste containing NovaMin (ReNew™, Sultan
Healthcare, Englewood, NJ). All toothpaste tubes were
covered with blinding labels and weighed before being
dispensed to subjects. At the baseline appointment,
Table 1 Baseline comparison between groups
ReNew™ Crest® P value (t-test)
Mean DI score 0.33 0.33 0.27
Mean GI score 2.14 2.15 0.95
Mean PI score 3.04 3.41 0.27
Mean age 15.6 15.3 0.63
Tx time 1.5 1.2 0.23
P value was set at 0.05. No significant difference between groups at baseline
were detected using two-sample t-test
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hygiene methods were reviewed, and photographs were
taken to capture a baseline assessment of the decalcifi-
cation index (DI). Subjects were instructed to bring the
tube of toothpaste to each monthly appointment, at
which time old toothpaste was collected, new tooth-
paste was dispensed, and oral hygiene instructions were
reinforced. Toothpaste was also weighed after collec-
tion as a means to measure patient compliance.
At the 3- and 6-month follow-up appointments, pictures
were taken, and the following clinical procedures were
carried out in the maxillary and mandibular anterior teeth:
1) Measurement of decalcification: the DI used in the
study was a modified version of the WSL index
developed by Gorelick et al.[9]. The modified
decalcification index scores individual teeth as
follows: (0) no white spot lesion present, (1) visible
white spots without surface interruption (mild
decalcification), (2) visible white spot lesion having a
roughened surface but not requiring a restoration
(moderate decalcification), (3) visible white spot
lesion with surface interruption (severe
decalcification), and (4) cavitation. DI scoring was
done with the photographs taken at the beginning of
the study serving as documentation. The same
camera settings were used throughout the study.
2) Measurement of gingivitis: we used the modified
gingival index (GI), defined by Lobene et al. [15], as
follows: (0) normal (no inflammation), (1) mild
inflammation (slight change in color, little change in
texture) of any portion of the gingival unit, (2) mild
inflammation of the entire gingival unit, (3)
moderate inflammation (moderate glazing, redness,
edema, and/or hypertrophy) of the entire gingival
unit, and (4) severe inflammation (marked redness
and edema/hypertrophy, spontaneous bleeding or
ulceration) of the gingival unit.
3) Measurement of plaque: the plaque index (PI) used
in this study was the Turesky modification of the
Quigley-Hein index [16]. Scoring used for this index
is on a zero to five scale and is defined as (0) no
plaque; (1) separate flecks or discontinuous bands of
plaque at the gingival margin; (2) thin (up to 1 mm),
continuous band of plaque at the gingival margin;
(3) band of plaque wider than 1 mm but less than one
third of the tooth surface; (4) plaque covering between
one third and two thirds of the tooth surface; and (5)
plaque covering more than two thirds of the tooth
surface.
4) Plaque bacterial counts: relative Streptococcus mutans
and Lactobacillus levels were measured in saliva
using a commercial caries risk test (CRT-Bacteria,
Ivoclar, Vivadent, Amherst, NY).Inter-examiner reliability was assessed between two
investigators (AEC and DAH) by scoring the indices of five
randomly selected patients and time points from the study
sample. Two-sample t-tests were used to test for differences
between treatment groups, while paired tests were used to
examine changes over time within treatment groups. Non-
parametric tests were also used (Wilcoxon rank-sum and
Wilcoxon signed-rank, respectively). While we expected
outcome variables to be normally distributed, differences
between parametric and non-parametric testing would alert
us to cases where this may not be true. Results did not vary;
thus, only the parametric results will be presented. A P
value less than 0.05 was considered statistically significant.
Chi-square tests, Fisher exact test, two sample t-tests, and
Wilcoxon rank-sum tests were used to analyze any signifi-
cant differences in regard to sex, race, age, and time in
treatment between the control and experimental groups.
Results
Statistical analysis showed that the groups were similar
regarding a number of variables at baseline, including age,
time in treatment, DI, GI, and PI scores (Table 1). They
also did not differ significantly with respect to sex (P =
0.54, chi-square test) or race (P = 0.72, Fisher exact test).
No clinical trends or statistically significant difference
between the control group (Crest®) and experimental
group (ReNew™) was noted throughout the 6-month
follow-up for PI (Fig. 1, Table 2). There was a trend toward
improvement in white spot lesions (DI score) found in
subjects using Crest® at the 3-month time point, which
was statistically significant (P = 0.0403) (Fig. 2, Table 2).
Likewise, the ReNew™ group showed a trend toward
improvement in gingival health at the 3-month time
point; however, no statistically significant difference
was detected (Fig. 3, Table 2). These improvements
were not sustained throughout the study since no sta-
tistically significant differences were detected between
the control and treatment groups at the 6-month time
point for all three indices (DI, GI, and PI).
We also examined change from baseline to 3 and
6 months, comparing the two groups. No statistically
significant differences were detected. Within-group com-
parisons detected significant changes from baseline to
Fig. 1 Mean plaque index (PI) score for each group throughout the
study. No statistically significant difference was found at 3
and 6 months
Table 2 Comparison at 3-month and 6-month intervals
Decalcification index (DI)
Number Mean Median St
dev




24 0.33 0.21 0.34 0 1.17
Baseline crest 24 0.330 0.250 0.4 0 1.33 0.97
3 month
ReNew
24 0.48 0.33 0.44 0 1.42
3 month crest 23 0.24 0.17 0.3 0 1.250 0.0403*
6 month
ReNew
23 0.47 0.42 0.37 0 1.58




24 3.04 3.250 1.33 0 4.92
Baseline crest 26 3.39 3.63 0.93 1.58 5 0.27
3 month
ReNew
24 3.22 3.42 1.16 1.17 5
3 month crest 23 3.48 3.33 0.9 1.750 4.83 0.41
6 month
ReNew
23 3.53 3.42 1.09 1.92 5




24 2.14 2.13 0.61 1.42 3.83
Baseline crest 24 2.15 2.250 0.47 1.250 3 0.95
3 month
ReNew
24 2.15 2.04 0.52 1.17 3
3 month crest 22 2.35 2.250 0.43 1.67 3.17 0.17
6 month
ReNew
23 2.42 2.33 0.560 1.33 3.42
6 month crest 21 2.5 2.42 0.63 1.33 4 0.69
P value was set at 0.05 using two-sample t-test
*P < 0.05 indicating a significant difference between groups for DI at 3 months
Fig. 2 Mean decalcification index (DI) score for each group 0–6 months.
*Statistically significant difference found at 3 months. This was not
realized at 6 months
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0.0453, 0.0405, respectively), indicating significant worsen-
ing over time for these indices. The control group had simi-
lar changes for DI and PI, which were of borderline
significance (P = 0.13, P = 0.09, respectively). A significant
increase in GI from baseline to 6 months was detected for
the control group (P = 0.0143), while a similar change of
borderline significance (0.06) was observed for the treat-
ment group.
No difference was found between groups in regard to
compliance: 41.7 % of subjects in each group were non-
compliant with the usage of dispensed toothpaste. Relative
bacteria counts of S. Mutans and Lactobacillus were
assessed between the ReNew™ and Crest® groups, and no
statistically significant difference was found between treat-
ment groups nor were differences detected in PI, GI, or
DI changes over 6 months when low- and high-bacteria
groups were compared (all P > 0.05).
Discussion
Use of calcium and phosphorous to prevent and/or
reverse white spot lesions shows promise in research
studies [17–19]. There are many different delivery
systems for calcium and phosphorous compounds. ForFig. 3 Mean gingival index (GI) score 0–6 months. No statistically
significant difference found at 3 and 6 moths
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research, we will consider all delivery vehicles to be
equally effective. Thus, our results are in agreement
with a study by Huang et al. [20] that showed no differ-
ence between MI Paste Plus, PreviDent mouthwash,
and standard homecare regarding improvement of WSL
over an 8-week period. Results are also in agreement
with the in vitro study by Ballard et al. [21] who tested
Restore (which contains NovaMin), PreviDent 5000,
and MI Paste Plus. Results of this study showed none
of these products were more effective at esthetically
resolving white spot lesions than a control.
A study by Robertson et al. [17] revealed a statistically
significant improvement in white spot lesions (WSL) using
MI Paste Plus, as compared to a control (Tom’s of Maine
toothpaste). In this study, 50 patients were followed for
3 months. Results showed a 53.5 % decrease in decalcifica-
tion index (DI) scores in the MI Paste Plus group, while the
control group showed a 91.1 % increase. Possible reasons
for the difference in this study may be due to the scoring
system used, which measured decalcification on a zero to
three scale based on size and did not take into account
surface roughness. This scoring system also divides the
facial surface of the tooth into quadrants (mesial, distal,
incisal, and gingival) increasing the amount of data points
available, thereby making any difference easier to detect.
Scoring was also assessed by means of photographs which
may not be as clinically accurate and could possibly induce
bias.
The role of fluoride in prevention of tooth decalcifica-
tion is well documented [7, 22–24]. Nevertheless, there
is debate regarding the amount of fluoride that should
be prescribed when remineralization of subsurface
enamel is desired [6, 25]. A limiting factor in gaining
remineralization, or reversal, of white spot lesions during
this study may have been the relatively high concentration
of fluoride in the ReNew™ dentifrice. High concentrations
of fluoride will lead to remineralization of the surface layer
with fluorapatite, which may inhibit remineralization of
subsurface layers [6]. This factor may help explain the
improvement seen in the control group (Crest®) at the 3-
month mark. Low levels of fluoride working in conjunction
with calcium and phosphorous found in saliva may have
led to a temporary improvement in white spot lesions. We
speculate that this transient improvement was eventually
overcome by the acidic attack from increasing plaque levels.
It is also possible that this group may have shown a transi-
ent improvement in hygiene, and hence white spot lesions,
for 1–2 months simply because they knew they were
enrolled in a study evaluating this outcome.
One vehicle which may be beneficial in providing the
calcium- and phosphorous-limiting remineralization is by
encouraging patients to chew gum with casein phospho-
peptide amorphous calcium phosphate (CPP-ACP). This incombination with fluoride levels found in over-the-counter
toothpastes may encourage reversal of WSL in orthodontic
patients. Another means to reverse WSL with CPP-ACP
would be the application of MI Paste Plus, after application
of phosphoric acid on the WSL for 30 s. Application of
phosphoric acid has proven beneficial in removing surface
proteins and fluorapatite for resin-infiltration procedures.
Further research is warranted to elucidate clinically predict-
able methods to prevent or reverse white spot lesions,
particularly in orthodontic patients.
Evidence-based dentistry has become a frequent issue in
recent dental literature [26]. In this randomized clinical
trial, we tried our best to exclude confounding factors that
may have interfered with the association between WSL/
gingivitis and dentifrice type. Nevertheless, we still faced
limitations that are now discussed. The most important
one is that plaque and gingival hyperplasia prevented a
completely accurate assessment of WSL in some patients.
After rinsing with a disclosing agent, patients were
instructed to brush until all plaque was removed. However,
some plaque typically remained especially in hard to reach
areas. A scaler was used to remove any remaining plaque,
although given clinical time restraints this was occasionally
difficult to achieve. Patient compliance is another limita-
tion of this study. Compliance, as measured by the weight
of returned toothpaste appears equal between both groups.
However, if a patient did return old tubes of toothpaste at
monthly visits, the patient was considered non-compliant,
when in reality he/she may have been compliant. A final
limitation of this study may have been the DI used. This
index is slightly subjective and rated white spot lesions on
a zero to four scale where patients rarely reached a score
of 2 or higher. Our patients typically showed WSL on only
a couple of anterior teeth. This may have made detecting a
true difference more difficult. Future studies may consider
using fluorescence technology.
Conclusions
Results of this study show there is no difference between an
over-the-counter fluoride containing toothpaste (Crest®)
versus a toothpaste containing NovaMin (ReNew™) in their
ability to improve white spot lesions, plaque levels, and
gingival health in orthodontic patients.
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